Investment Review №334. Customer return

 

Vox Royalty Corp. (VOXR) is a Toronto-based company that acquires royalty rights in mining (primarily gold) projects, with operating risks borne by the mine owners and operators. VOXR provides liquidity to exploration and mining companies and expands its portfolio through its proprietary Mineral Royalties Online (MRO) base, which includes over 8,500 projects. Royalties, typically 1–5% of revenue or production, generate relatively stable income without direct operational involvement. Vox’s latest quarterly results surpassed expectations: administrative expenses declined 14% YoY to $1.05 million, reflecting improved operating efficiency. Liquidity has significantly strengthened due to the $63.25 million raised and an increase in the BMO credit facility to $75 million. Key organic growth drivers include anticipated development decisions regarding the Sulphur Springs and Horseshoe Lights projects, as well as new studies at Ashburton, Bulgera, and Estrades. Besides, the acquisition of 10 gold royalties from Deterra Royalties is expected to add approximately $7 million in annualized revenue starting in 2026. Freedom Broker estimates the stock’s fair value at $5.80 on a one-year investment horizon.

 

Black Diamond Therapeutics, Inc. (BDTX) is a clinical-stage biotechnology company focused on precision oncology. It is developing orally administered, brain-penetrant molecule drugs designed to target clusters of oncogenic mutations. The company uses its proprietary MAP platform to create inhibitors aimed at families of genetic alterations that drive tumor growth. BDTX has recently completed patient enrollment in the third cohort of a Phase II trial evaluating silevertinib as a first-line treatment for non-small cell lung cancer (NSCLC) with rare EGFR mutations. Publication of objective response rate and duration-of-response data is expected by the end of Q4 2025. Last quarter, operating expenses came in below forecasts, due to lower-than-expected development costs for silevertinib. The company reported $135.5 million in cash, which is sufficient to fund operations through Q4 2027. Given the company’s stable clinical progress and solid financial position, Freedom Broker estimates a 12-month fair value for the shares at $6.00.

 

Adient plc (ADNT) is a leading global manufacturer of automotive seating, supplying the full product cycle—from metal frames to finished seats—to most major automakers, including Volkswagen Group (VOW3), Ford Motor Co. (F), and Stellantis N.V. (STLA). Last quarter, the company’s fundamentals were supported by solid underlying operating performance across all regions and prudent capital management, which helped offset lower production volumes at customers. Management continued to deliver on its commitment to shareholders by allocating $125 million for share repurchases, while also strengthening the company’s capital structure through an extension of its ABL credit facility. Management has issued a cautious outlook for fiscal year 2026, expecting strong internal financial performance to be largely offset by external headwinds, primarily lower production at key customers. This has contributed to a pullback in the share price, creating an opportunity to open a long. Freedom Broker estimates the stock’s fair value at $28.0 on a one-year horizon.

 

Contango Ore, Inc. (CTGO) is a recent explorer and now a gold producer. The company began selling gold in Q3 2025. Its deposits have significant potential for production growth. At the Manh Choh project, the mining plan envisions two small open pits being developed simultaneously over a 4.5‑year period. Historical mining activity in the surrounding area increases the likelihood of additional gold discoveries and suggests considerable upside to the current resource base. Total life-of-mine all-in sustaining costs (LOM AISC) are estimated at $1,400 per ounce (vs. initial guidance of $1,116), which remains acceptable with current gold prices above $4,000 per ounce. The company is also advancing exploration across several promising assets, including Johnson Tract, and the HighGold and Lucky Shot deposits. Successful development or resource expansion at these sites could remove a “single-asset discount” currently embedded in CTGO’s valuation. Freedom Broker estimates a one-year fair value target of $41.00 per share.